product summary
company name :
Developmental Studies Hybridoma Bank
product type :
antibody
product name :
Mechanistic Target Of Rapamycin Peptide 5
catalog :
CPTC-mTOR-8
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
CPTC-mTOR-8
reactivity :
human
more info or order :
product information
Internal ID :
30076
Name :
CPTC-mTOR-8
Depositor Name :
Clinical Proteomics Technologies for Cancer
Depositor Institution :
National Cancer Institute
Depositor Website :
http://proteomics.cancer.gov
Date Deposited :
1/25/17
Allow Hybridoma Distribution :
No
Cells Available (legacy) :
No
Antigen :
Mechanistic Target Of Rapamycin Peptide 5
Antigen Species :
Human
Host Species :
mouse
Isotype :
MIgG1, kappa light chain
Positive Tested Species Reactivity :
Human
Depositor Notes (Special Instructions) :
This antigen is also known as serine/threonine-protein kinase mTOR.
Collections :
Cancer targets - NCI,Enzymes,Human
Search Keywords :
Clinical Proteomics Technologies for Cancer,
Mechanistic Target Of Rapamycin Peptide 5, Human, MIgG1, kappa light chain, Human, mTOR, FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1, , Monoclonal, Human/nci - cancer targets/enzymes,
Antigen Molecular Weight :
288.8 kDa
Gene :
mTOR
Alternate Gene Name(s) :
FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1
Uniprot ID :
P42345
Antibody Registry ID :
AB_2722092
Immunogen :
Synthetic peptide
Immunogen Sequence :
DLELAVPGTYDPNQPIIR (a.a. 2135-2152)
Clonality :
Monoclonal
Myeloma Strain :
P3x63Ag8.653
Epitope Mapped :
Yes
Additional Information :
RRID:AB_2722092
DSHB Growth Medium :
Iscove's
more info or order :
company information
Developmental Studies Hybridoma Bank
review
product type
related products
browse more products
- PTEN/ Phosphatase And Tensin Homolog Peptide 1 | CPTC-PTEN-3
- PTEN/ Phosphatase And Tensin Homolog Peptide 2 | CPTC-PTEN-4
- PTEN/ Phosphatase And Tensin Homolog Peptide 4 | CPTC-PTEN-5
- PTEN/ Phosphatase And Tensin Homolog Peptide 4 | CPTC-PTEN-6
- PTEN/ Phosphatase And Tensin Homolog Peptide 4 | CPTC-PTEN-7
questions and comments